Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission

This study is ongoing, but not recruiting participants.

Study NCT00002977 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Ovarian Cancer

Additional conditions recognized in this trial

Ovarian Neoplasms

More general conditions related to this trial

Interventions listed in this trial

filgrastim
melphalan
thiotepa

More general drug interventions related to this trial

Sponsors listed in this trial